Joint (intra-articular or IA) injections are often performed to treat joint inflammation and injury. This delivers treatment directly into the joint, ensuring the therapeutics are present where they are most needed, as opposed to systemic treatments (i.e., given intravenously, orally, or intramuscularly) that have to travel through the body to the site of injury or disease.

For the first time, researchers have unveiled an intervention that appears to slow down the progression of osteoarthritis (OA). A clinical study conducted jointly by the Swedish University of Agricultural Sciences (SLU) and the University of Gothenburg (UGOT), Sweden, has yielded remarkable results. Horses afflicted with OA, treated with a novel drug combination, not only achieved freedom from lameness but also experienced a simultaneous inhibition of joint tissue degradation.

The musculoskeletal system of the horse is an incredible machine — strong, fast, efficient, and capable of performing feats as varied as jumping obstacles and roping cattle. However, horse owners are all too aware of the fact that despite this amazing athletic ability, the equine body can be remarkably fragile. If one owns horses long enough, he or she is bound to encounter a disorder of the equine musculoskeletal system.

WorkSafeBC